Quantum Biopharma has filed with the FDA to start a Phase 2 trial of Lucid-MS to assess the treatment's ability to halt ...
King Faisal Specialist Hospital & Research Centre (KFSH) successfully applied gene therapy in a patient with sickle cell ...
World Quantum Day Event to Spotlight Local Startups and Academic Institutions Quantum Day Pasadena will bring together ...
The associate professor and researcher in quantum technologies at the University of Oxford talks to Reuters about the ...
In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.
Shares of Quantum BioPharma (QNTM) surged 15% in pre-market trading on Monday after the biotech firm signed a binding ...
Marvel's Quantum Realm from Avengers Endgame and Ant-Man and the Wasp finally, fully explained! Video Sponsored by Ridge ...
Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...
Joseph Thomas, MD, MBA, Fellow of Metabolic and Nutritional Medicine In collaboration with Oxygen Health Systems Abstract ...
A single beam of entangled light, generated by equipment found in laboratories around the world, has been concealing one of ...